GlassScriptPhysician profile
Christopher J Barry
NPI 1588629943
$180,964.98
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139K · 2020: $20K · 2021: $6,841 · 2022: $14K · 2023: $2,338 · 2024: $57.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,166 · Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,166.00 |
| Food and Beverage | $229.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synergy Integrated Medical Solutions LLC | $158,000.00 | 2019-2020 | |
| Medtronic, INC. | $15,352.30 | 2021-2022 | |
| Tyber Medical, LLC | $7,073.00 | 2021-2023 | |
| Medtronic USA, INC. | $187.19 | 2019-2020 | |
| Centinel Spine, LLC | $172.40 | 2023 | Prodisc C Vivo |
| Cerapedics INC. | $98.99 | 2022 | |
| Orthofix Medical, INC. | $57.13 | 2024 | Regatta Lateral System |
| Depuy Synthes Sales INC. | $23.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,009,650.96 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Barry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.